- Home
- AGMH vs IXHL Comparison
AGMH vs IXHL Comparison
Compare AGMH & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGMH
- IXHL
- Stock Information
- Founded
- AGMH 2015
- IXHL 2001
- Country
- AGMH Hong Kong
- IXHL Australia
- Employees
- AGMH N/A
- IXHL N/A
- Industry
- AGMH EDP Services
- IXHL
- Sector
- AGMH Technology
- IXHL
- Exchange
- AGMH Nasdaq
- IXHL Nasdaq
- Market Cap
- AGMH 42.4M
- IXHL 39.2M
- IPO Year
- AGMH 2018
- IXHL N/A
- Fundamental
- Price
- AGMH $1.28
- IXHL $1.93
- Analyst Decision
- AGMH
- IXHL
- Analyst Count
- AGMH 0
- IXHL 0
- Target Price
- AGMH N/A
- IXHL N/A
- AVG Volume (30 Days)
- AGMH 114.2K
- IXHL 24.2K
- Earning Date
- AGMH 01-28-2025
- IXHL 11-14-2024
- Dividend Yield
- AGMH N/A
- IXHL N/A
- EPS Growth
- AGMH N/A
- IXHL N/A
- EPS
- AGMH N/A
- IXHL N/A
- Revenue
- AGMH $64,998,081.00
- IXHL $86,000.00
- Revenue This Year
- AGMH N/A
- IXHL $3,817.06
- Revenue Next Year
- AGMH N/A
- IXHL $66.67
- P/E Ratio
- AGMH N/A
- IXHL N/A
- Revenue Growth
- AGMH N/A
- IXHL N/A
- 52 Week Low
- AGMH $0.47
- IXHL $1.50
- 52 Week High
- AGMH $2.20
- IXHL $8.47
- Technical
- Relative Strength Index (RSI)
- AGMH 38.42
- IXHL 52.16
- Support Level
- AGMH $1.22
- IXHL $1.71
- Resistance Level
- AGMH $1.42
- IXHL $2.19
- Average True Range (ATR)
- AGMH 0.11
- IXHL 0.16
- MACD
- AGMH -0.01
- IXHL -0.00
- Stochastic Oscillator
- AGMH 23.98
- IXHL 41.12
About AGMH AGM Group Holdings Inc.
AGM Group Holdings Inc is an investment holding company. The company focuses on blockchain-oriented ASIC chip design; high-end crypto miner production and fintech technology software service. It generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.